Skip to main content

Find Clinical Trials

Home
Conditions
Hepatocellular Cancer

Clinical trial condition

Hepatocellular Cancer

Explore clinical trials studying Hepatocellular Cancer. Study availability and eligibility vary by location and protocol.

57 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Cancer trial results

Completed

A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer

NCT01522937

Conditions: Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +5 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases

NCT00465023

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
Locations: Not specified

View Trial Details

Completed

Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients

NCT00997022

Conditions: Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +4 more
Locations: University of Southern California Los Angeles, California, United States

University of California, Los Angeles Los Angeles, California, United States

Columbia University Medical Center New York, United States

View Trial Details

Active, Not Recruiting

Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma

NCT03937830

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

NCT02954094

Conditions: Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +4 more
Locations: Banner University Medical Center Phoenix, Arizona, United States

University of Arkansas Little Rock, Arkansas, United States

University of Southern California/Norris Comprehensive Cancer Center Los Angeles, California, United States

Stanford University Palo Alto, California, United States

View all 71 locations

View Trial Details

Active, Not Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

NCT05438420

Conditions: Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +25 more
Locations: University of Southern California Los Angeles, California, United States

Norton Cancer Institute Louisville, Kentucky, United States

CHA Bundang Medical Center Seongnam-si, South Korea

Asan Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

NCT05064553

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +24 more
Locations: Arizona Health Research Chandler, Arizona, United States

Arizona Digestive Health - Sun City Sun City, Arizona, United States

Franco Felizarta, MD Bakersfield, California, United States

Gastroenterology & Liver Institute Escondido, California, United States

View all 76 locations

View Trial Details